Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION
| Report ID | 170890 |
| Drug Identification Number | 02395150 |
| Brand name | 0.9% SODIUM CHLORIDE INJECTION |
| Common or Proper name | 0.9% SODIUM CHLORIDE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 900MG |
| Dosage form(s) | SOLUTION SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-10-01 |
| Estimated end date | Unknown |
| Actual end date | 2022-11-30 |
| Shortage status | Resolved |
| Updated date | 2022-12-04 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-12-04 | French | Compare |
| v3 | 2022-12-04 | English | Compare |
| v2 | 2022-10-02 | French | Compare |
| v1 | 2022-10-02 | English | Compare |
Showing 1 to 4 of 4